Thomas Frederick Newton, M.D. - Publications

Affiliations: 
Psychiatry Baylor College of Medicine, Houston, TX 
Area:
Addiction Neuroscience
Website:
http://www.bcm.edu/psychiatry/index.cfm?pmid=8872

83 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2018 Wang JM, Zhu L, Brown VM, De La Garza R, Newton T, King-Casas B, Chiu PH. In Cocaine Dependence, Neural Prediction Errors During Loss Avoidance Are Increased With Cocaine Deprivation and Predict Drug Use. Biological Psychiatry. Cognitive Neuroscience and Neuroimaging. PMID 30297162 DOI: 10.1016/J.Bpsc.2018.07.009  0.305
2018 Patel MM, Nielsen DA, Kosten TR, De La Garza R, Newton TF, Verrico CD. FAAH variant Pro129Thr modulates subjective effects produced by cocaine administration. The American Journal On Addictions. PMID 30126012 DOI: 10.1111/Ajad.12788  0.717
2017 Mahoney JJ, Kalechstein AD, Newton TF, De La Garza R. The limited impact that cocaine use patterns have on neurocognitive functioning in individuals with cocaine use disorder. Journal of Psychopharmacology (Oxford, England). 269881117715606. PMID 28695777 DOI: 10.1177/0269881117715606  0.42
2017 Mathai DS, Holst M, Rodgman C, Haile CN, Keller J, Hussain MZ, Kosten TR, Newton TF, Verrico CD. Guanfacine Attenuates Adverse Effects of Dronabinol (THC) on Working Memory in Adolescent-Onset Heavy Cannabis Users: A Pilot Study. The Journal of Neuropsychiatry and Clinical Neurosciences. appineuropsych161203. PMID 28641496 DOI: 10.1176/Appi.Neuropsych.16120328  0.645
2017 Patriquin MA, Hamon SC, Harding MJ, Nielsen EM, Newton TF, De La Garza R, Nielsen DA. Genetic moderation of cocaine subjective effects by variation in the TPH1, TPH2, and SLC6A4 serotonin genes. Psychiatric Genetics. PMID 28590957 DOI: 10.1097/YPG.0000000000000178  0.419
2017 Mahoney JJ, Haile CN, De La Garza R, Thakkar H, Newton TF. Electrocardiographic characteristics in individuals with cocaine use disorder. The American Journal On Addictions. PMID 28248441 DOI: 10.1111/ajad.12524  0.41
2017 Mahoney JJ, Kalechstein AD, De Marco AP, Newton TF, De La Garza R. The Relationship Between Premorbid IQ and Neurocognitive Functioning in Individuals With Cocaine Use Disorders. Neuropsychology. PMID 28054825 DOI: 10.1037/neu0000344  0.399
2016 De La Garza R, Yoon JH, Thompson-Lake DG, Haile CN, Eisenhofer JD, Newton TF, Mahoney JJ. Treadmill exercise improves fitness and reduces craving and use of cocaine in individuals with concurrent cocaine and tobacco-use disorder. Psychiatry Research. 245: 133-140. PMID 27541349 DOI: 10.1016/J.Psychres.2016.08.003  0.371
2016 Grasing K, Mathur D, DeSouza C, Newton TF, Moody DE, Sturgill M. Cocaine cardiovascular effects and pharmacokinetics after treatment with the acetylcholinesterase inhibitor donepezil. The American Journal On Addictions / American Academy of Psychiatrists in Alcoholism and Addictions. PMID 27392137 DOI: 10.1111/Ajad.12402  0.434
2016 Shorter D, Nielsen DA, Hamon SC, Nielsen EM, Kosten TR, Newton TF, De La Garza R. The α-1 adrenoceptor (ADRA1A) genotype moderates the magnitude of acute cocaine-induced subjective effects in cocaine-dependent individuals. Pharmacogenetics and Genomics. PMID 27379509 DOI: 10.1097/Fpc.0000000000000234  0.436
2016 Rodgman C, Verrico CD, Holst M, Thompson-Lake D, Haile CN, De La Garza R, Raskind MA, Newton TF. Doxazosin XL reduces symptoms of posttraumatic stress disorder in veterans with PTSD: a pilot clinical trial. The Journal of Clinical Psychiatry. 77: e561-e565. PMID 27249080 DOI: 10.4088/Jcp.14M09681  0.589
2016 Verrico CD, Haile CN, De La Garza R, Grasing K, Kosten TR, Newton TF. Subjective and Cardiovascular Effects of Intravenous Methamphetamine during Perindopril Maintenance: A Randomized, Double-Blind, Placebo-Controlled Human Laboratory Study. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). PMID 27207905 DOI: 10.1093/Ijnp/Pyw029  0.64
2015 De La Garza R, Verrico CD, Newton TF, Mahoney JJ, Thompson-Lake DG. Safety and Preliminary Efficacy of the Acetylcholinesterase Inhibitor Huperzine A as a Treatment for Cocaine Use Disorder. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). PMID 26364275 DOI: 10.1093/Ijnp/Pyv098  0.7
2015 Newton TF, Haile CN, Mahoney JJ, Shah R, Verrico CD, De La Garza R, Kosten TR. Dopamine D3 receptor-preferring agonist enhances the subjective effects of cocaine in humans. Psychiatry Research. 230: 44-9. PMID 26239766 DOI: 10.1016/J.Psychres.2015.07.073  0.728
2015 Brewer AJ, Nielsen DA, Spellicy CJ, Hamon SC, Gingrich J, Thompson-Lake DG, Nielsen EM, Mahoney JJ, Kosten TR, Newton TF, De La Garza R. Genetic variation of the dopamine transporter (DAT1) influences the acute subjective responses to cocaine in volunteers with cocaine use disorders. Pharmacogenetics and Genomics. 25: 296-304. PMID 25850966 DOI: 10.1097/Fpc.0000000000000137  0.42
2015 De La Garza R, Bubar MJ, Carbone CL, Moeller FG, Newton TF, Anastasio NC, Harper TA, Ware DL, Fuller MA, Holstein GJ, Jayroe JB, Bandak SI, Reiman KZ, Neale AC, Pickford LB, et al. Evaluation of the dopamine β-hydroxylase (DβH) inhibitor nepicastat in participants who meet criteria for cocaine use disorder. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 59: 40-8. PMID 25602710 DOI: 10.1016/J.Pnpbp.2015.01.009  0.482
2015 Mahoney JJ, Thompson-Lake DG, Cooper K, Verrico CD, Newton TF, De La Garza R. A comparison of impulsivity, depressive symptoms, lifetime stress and sensation seeking in healthy controls versus participants with cocaine or methamphetamine use disorders. Journal of Psychopharmacology (Oxford, England). 29: 50-6. PMID 25424624 DOI: 10.1177/0269881114560182  0.683
2015 Thompson-Lake DG, Hernandez S, Holst M, Mahoney J, Haile CN, Newton TF, Garza RDL, Psychiatry I. An in-depth analysis of cocaine-induced negative subjective effects in humans Drug and Alcohol Dependence. 156: e220-e221. DOI: 10.1016/j.drugalcdep.2015.07.594  0.416
2015 Nielsen DA, Hamon S, Harding M, Nielsen EM, Kosten T, Newton TF, De La Garza R. Ubjective responses to acute cocaine are moderated by variants of the serotonergic system Drug and Alcohol Dependence. 156: e162-e163. DOI: 10.1016/J.Drugalcdep.2015.07.443  0.362
2015 Haile CN, Verrico CD, Thompson-Lake DG, Mahoney JJ, Kosten T, De La Garza R, Newton TF. The angiotensin receptor blocker candesartan attenuates the subjective effects of methamphetamine in humans Drug and Alcohol Dependence. 156: e88. DOI: 10.1016/J.Drugalcdep.2015.07.1155  0.608
2015 Verrico CD, Thompson-Lake DG, Iqbal T, Mahoney J, Kosten T, Newton TF, De La Garza R. Evaluation of guanfacine administration on cognition in volunteers with cannabis-use disorder Drug and Alcohol Dependence. 146: e11. DOI: 10.1016/J.Drugalcdep.2014.09.711  0.594
2015 Haile CN, Thompson-Lake DG, Mahoney JJ, Newton TF, Garza RDL. Cocaine-induced subjective effects differ between African Americans and Caucasians Drug and Alcohol Dependence. 146: e133. DOI: 10.1016/j.drugalcdep.2014.09.280  0.395
2015 Brewer A, Thompson-Lake DG, Mahoney JJ, Newton TF, De La Garza R. Evaluation of lisdexamfetamine alone and lisdexamfetamine+modafinil for cocaine use disorder Drug and Alcohol Dependence. 146: e231. DOI: 10.1016/J.Drugalcdep.2014.09.095  0.401
2014 Wesley MJ, Lohrenz T, Koffarnus MN, McClure SM, De La Garza R, Salas R, Thompson-Lake DG, Newton TF, Bickel WK, Montague PR. Choosing Money over Drugs: The Neural Underpinnings of Difficult Choice in Chronic Cocaine Users. Journal of Addiction. 2014: 189853. PMID 25197609 DOI: 10.1155/2014/189853  0.406
2014 Mahoney JJ, De La Garza R, Jackson BJ, Verrico CD, Ho A, Iqbal T, Newton TF. The relationship between sleep and drug use characteristics in participants with cocaine or methamphetamine use disorders. Psychiatry Research. 219: 367-71. PMID 24951161 DOI: 10.1016/J.Psychres.2014.05.026  0.684
2014 Verrico CD, Haile CN, Mahoney JJ, Thompson-Lake DG, Newton TF, De La Garza R. Treatment with modafinil and escitalopram, alone and in combination, on cocaine-induced effects: a randomized, double blind, placebo-controlled human laboratory study. Drug and Alcohol Dependence. 141: 72-8. PMID 24928479 DOI: 10.1016/J.Drugalcdep.2014.05.008  0.71
2014 Spellicy CJ, Harding MJ, Hamon SC, Mahoney JJ, Reyes JA, Kosten TR, Newton TF, De La Garza R, Nielsen DA. A variant in ANKK1 modulates acute subjective effects of cocaine: a preliminary study. Genes, Brain, and Behavior. 13: 559-64. PMID 24528631 DOI: 10.1111/Gbb.12121  0.536
2014 Verrico CD, Mahoney JJ, Thompson-Lake DG, Bennett RS, Newton TF, De La Garza R. Safety and efficacy of varenicline to reduce positive subjective effects produced by methamphetamine in methamphetamine-dependent volunteers. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 17: 223-33. PMID 24393456 DOI: 10.1017/S146114571300134X  0.643
2014 De La Garza R, Galloway GP, Newton TF, Mendelson J, Haile CN, Dib E, Hawkins RY, Chen CY, Mahoney JJ, Mojsiak J, Lao G, Anderson A, Kahn R. Assessment of safety, cardiovascular and subjective effects after intravenous cocaine and lofexidine. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 50: 44-52. PMID 24316175 DOI: 10.1016/j.pnpbp.2013.11.013  0.441
2014 Newton TF, Haile CN, Mahoney JJ, Shah R, Verrico CD, De La Garza R, Kosten TR. Dopamine D3 receptor-preferring agonist enhances the subjective effects of cocaine in humans Psychiatry Research. DOI: 10.1016/j.psychres.2015.07.073  0.684
2014 Verrico CD, Nielsen D, Spellicy C, Hamon S, Kosten T, Newton TF, Ii RDLG. Fatty acid amide hydrolase gene variant influences acute responses to cocaine Drug and Alcohol Dependence. 140: e234. DOI: 10.1016/J.Drugalcdep.2014.02.648  0.646
2014 Shorter D, Nielsen DA, Newton TF, De La Garza R, Kosten T. Association between α-1 adrenergic receptor (ADRA1A) genotype and subjective cocaine effect in cocaine-dependent individuals Drug and Alcohol Dependence. 140: e207. DOI: 10.1016/J.Drugalcdep.2014.02.575  0.4
2014 Nielsen DA, Spellicy C, Hamon S, Harding M, Mahoney JJ, Kosten T, De La Garza Ii R, Newton TF. Genetic variants of the dopaminergic system associated with subjective responses to cocaine Drug and Alcohol Dependence. 140: e161. DOI: 10.1016/J.Drugalcdep.2014.02.455  0.389
2014 Mahoney JJ, Kalechstein A, Newton TF, Meyer S, Verrico C, Bennett R, Chang L, Garza RDL. State versus trait: Evaluating the stability of neurocognitive functioning over time in cocaine-dependent participants Drug and Alcohol Dependence. 140: e132. DOI: 10.1016/j.drugalcdep.2014.02.376  0.662
2014 Brewer A, Nielsen DA, Spellicy C, Hamon S, Gingrich J, Mahoney JJ, Kosten T, Newton TF, Garza RDL. Subjective effects produced by cocaine are in association with genetic variants of DAT1 Drug and Alcohol Dependence. 140: e19-e20. DOI: 10.1016/J.Drugalcdep.2014.02.075  0.389
2013 Verrico CD, Haile CN, Newton TF, Kosten TR, De La Garza R, De La Garza R. Pharmacotherapeutics for substance-use disorders: a focus on dopaminergic medications. Expert Opinion On Investigational Drugs. 22: 1549-68. PMID 24033127 DOI: 10.1517/13543784.2013.836488  0.66
2013 Grasing K, Mathur D, Newton TF, Desouza C. Individual predictors of the subjective effects of intravenous cocaine. Psychiatry Research. 208: 245-51. PMID 23768613 DOI: 10.1016/J.Psychres.2013.05.028  0.447
2013 Brewer AJ, Mahoney JJ, Nerumalla CS, Newton TF, De La Garza R. The influence of smoking cigarettes on the high and desire for cocaine among active cocaine users. Pharmacology, Biochemistry, and Behavior. 106: 132-6. PMID 23541494 DOI: 10.1016/J.Pbb.2013.03.008  0.344
2012 Haile CN, Hao Y, O'Malley PW, Newton TF, Kosten TA. The α1 Antagonist Doxazosin Alters the Behavioral Effects of Cocaine in Rats. Brain Sciences. 2: 619-33. PMID 24961263 DOI: 10.3390/Brainsci2040619  0.421
2012 Haile CN, De La Garza R, Mahoney JJ, Nielsen DA, Kosten TR, Newton TF. The impact of disulfiram treatment on the reinforcing effects of cocaine: a randomized clinical trial. Plos One. 7: e47702. PMID 23144826 DOI: 10.1371/Journal.Pone.0047702  0.436
2012 Kalechstein AD, Yoon JH, Mahoney JJ, Newton TF, Chang L, De La Garza R. d-Cycloserine administration does not affect neurocognition in concurrent cocaine- and nicotine-dependent volunteers. Pharmacology, Biochemistry, and Behavior. 103: 403-7. PMID 22960612 DOI: 10.1016/j.pbb.2012.08.011  0.372
2012 Haile CN, Mahoney JJ, Newton TF, De La Garza R. Pharmacotherapeutics directed at deficiencies associated with cocaine dependence: focus on dopamine, norepinephrine and glutamate. Pharmacology & Therapeutics. 134: 260-77. PMID 22327234 DOI: 10.1016/j.pharmthera.2012.01.010  0.43
2012 Newton TF, De La Garza R, Brown G, Kosten TR, Mahoney JJ, Haile CN. Noradrenergic α₁ receptor antagonist treatment attenuates positive subjective effects of cocaine in humans: a randomized trial. Plos One. 7: e30854. PMID 22319592 DOI: 10.1371/Journal.Pone.0030854  0.477
2012 De La Garza R, Newton TF, Haile CN, Yoon JH, Nerumalla CS, Mahoney JJ, Aziziyeh A. Rivastigmine reduces "Likely to use methamphetamine" in methamphetamine-dependent volunteers. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 37: 141-6. PMID 22230648 DOI: 10.1016/J.Pnpbp.2011.12.014  0.304
2011 Roache JD, Kahn R, Newton TF, Wallace CL, Murff WL, De La Garza R, Rivera O, Anderson A, Mojsiak J, Elkashef A. A double-blind, placebo-controlled assessment of the safety of potential interactions between intravenous cocaine, ethanol, and oral disulfiram. Drug and Alcohol Dependence. 119: 37-45. PMID 21696894 DOI: 10.1016/J.Drugalcdep.2011.05.015  0.509
2011 Tziortzis D, Mahoney JJ, Kalechstein AD, Newton TF, De La Garza R. The relationship between impulsivity and craving in cocaine- and methamphetamine-dependent volunteers. Pharmacology, Biochemistry, and Behavior. 98: 196-202. PMID 21215769 DOI: 10.1016/J.Pbb.2010.12.022  0.402
2010 Haile CN, De La Garza R, Newton TF. Methamphetamine Cured my Cocaine Addiction. Journal of Addiction Research & Therapy. 1. PMID 23066512 DOI: 10.4172/2155-6105.1000103  0.52
2010 Grasing K, Mathur D, Newton TF, DeSouza C. Donepezil treatment and the subjective effects of intravenous cocaine in dependent individuals. Drug and Alcohol Dependence. 107: 69-75. PMID 19836169 DOI: 10.1016/J.Drugalcdep.2009.09.010  0.468
2009 De La Garza R, Ashbrook LH, Evans SE, Jacobsen CA, Kalechstein AD, Newton TF. Influence of verbal recall of a recent stress experience on anxiety and desire for cocaine in non-treatment seeking, cocaine-addicted volunteers. The American Journal On Addictions / American Academy of Psychiatrists in Alcoholism and Addictions. 18: 481-7. PMID 19874169 DOI: 10.3109/10550490903205876  0.352
2009 Kalechstein AD, De la Garza R, Newton TF, Green MF, Cook IA, Leuchter AF. Quantitative EEG abnormalities are associated with memory impairment in recently abstinent methamphetamine-dependent individuals. The Journal of Neuropsychiatry and Clinical Neurosciences. 21: 254-8. PMID 19776303 DOI: 10.1176/JNP.2009.21.3.254  0.305
2009 De La Garza R, Zorick T, Heinzerling KG, Nusinowitz S, London ED, Shoptaw S, Moody DE, Newton TF. The cardiovascular and subjective effects of methamphetamine combined with gamma-vinyl-gamma-aminobutyric acid (GVG) in non-treatment seeking methamphetamine-dependent volunteers. Pharmacology, Biochemistry, and Behavior. 94: 186-93. PMID 19698734 DOI: 10.1016/J.Pbb.2009.08.007  0.316
2008 Fleury G, De La Garza R, Mahoney JJ, Evans SE, Newton TF. Predictors of cardiovascular response to methamphetamine administration in methamphetamine-dependent individuals. The American Journal On Addictions / American Academy of Psychiatrists in Alcoholism and Addictions. 17: 103-10. PMID 18393052 DOI: 10.1080/10550490701861078  0.352
2008 Mahoney JJ, Kalechstein AD, De La Garza R, Newton TF. Presence and persistence of psychotic symptoms in cocaine- versus methamphetamine-dependent participants. The American Journal On Addictions / American Academy of Psychiatrists in Alcoholism and Addictions. 17: 83-98. PMID 18393050 DOI: 10.1080/10550490701861201  0.478
2008 De La Garza R, Shoptaw S, Newton TF. Evaluation of the cardiovascular and subjective effects of rivastigmine in combination with methamphetamine in methamphetamine-dependent human volunteers. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 11: 729-41. PMID 18248689 DOI: 10.1017/S1461145708008456  0.417
2008 De La Garza R, Mahoney JJ, Culbertson C, Shoptaw S, Newton TF. The acetylcholinesterase inhibitor rivastigmine does not alter total choices for methamphetamine, but may reduce positive subjective effects, in a laboratory model of intravenous self-administration in human volunteers. Pharmacology, Biochemistry, and Behavior. 89: 200-8. PMID 18207225 DOI: 10.1016/J.Pbb.2007.12.010  0.391
2007 Kalechstein AD, Fong T, Rosenthal RJ, Davis A, Vanyo H, Newton TF. Pathological gamblers demonstrate frontal lobe impairment consistent with that of methamphetamine-dependent individuals. The Journal of Neuropsychiatry and Clinical Neurosciences. 19: 298-303. PMID 17827415 DOI: 10.1176/Jnp.2007.19.3.298  0.359
2007 Rotheram-Fuller E, De La Garza R, Mahoney JJ, Shoptaw S, Newton TF. Subjective and cardiovascular effects of cocaine during treatment with amantadine and baclofen in combination. Psychiatry Research. 152: 205-10. PMID 17449110 DOI: 10.1016/J.Psychres.2006.03.012  0.539
2007 Mahoney JJ, Kalechstein AD, De La Garza R, Newton TF. A qualitative and quantitative review of cocaine-induced craving: the phenomenon of priming. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 31: 593-9. PMID 17270333 DOI: 10.1016/J.Pnpbp.2006.12.004  0.494
2007 Irwin MR, Olmos L, Wang M, Valladares EM, Motivala SJ, Fong T, Newton T, Butch A, Olmstead R, Cole SW. Cocaine dependence and acute cocaine induce decreases of monocyte proinflammatory cytokine expression across the diurnal period: autonomic mechanisms. The Journal of Pharmacology and Experimental Therapeutics. 320: 507-15. PMID 17068203 DOI: 10.1124/Jpet.106.112797  0.454
2006 Venneman S, Leuchter A, Bartzokis G, Beckson M, Simon SL, Schaefer M, Rawson R, Newton T, Cook IA, Uijtdehaage S, Ling W. Variation in neurophysiological function and evidence of quantitative electroencephalogram discordance: predicting cocaine-dependent treatment attrition. The Journal of Neuropsychiatry and Clinical Neurosciences. 18: 208-16. PMID 16720798 DOI: 10.1176/Jnp.2006.18.2.208  0.404
2005 Newton TF, De La Garza R, Fong T, Chiang N, Holmes TH, Bloch DA, Anderson A, Elkashef A. A comprehensive assessment of the safety of intravenous methamphetamine administration during treatment with selegiline. Pharmacology, Biochemistry, and Behavior. 82: 704-11. PMID 16413604 DOI: 10.1016/J.Pbb.2005.11.012  0.445
2005 Newton TF, Kalechstein AD, De La Garza R, Cutting DJ, Ling W. Apathy predicts hedonic but not craving response to cocaine. Pharmacology, Biochemistry, and Behavior. 82: 236-40. PMID 16181666 DOI: 10.1016/J.Pbb.2005.08.016  0.514
2005 Newton TF, Roache JD, De La Garza R, Fong T, Wallace CL, Li SH, Elkashef A, Chiang N, Kahn R. Safety of intravenous methamphetamine administration during treatment with bupropion. Psychopharmacology. 182: 426-35. PMID 16163531 DOI: 10.1007/S00213-005-0102-8  0.397
2005 Newton TF, De La Garza R, Kalechstein AD, Nestor L. Cocaine and methamphetamine produce different patterns of subjective and cardiovascular effects. Pharmacology, Biochemistry, and Behavior. 82: 90-7. PMID 16112720 DOI: 10.1016/J.Pbb.2005.07.012  0.483
2005 De La Garza R, Newton TF, Kalechstein AD. Risperidone diminishes cocaine-induced craving. Psychopharmacology. 178: 347-50. PMID 15452684 DOI: 10.1007/S00213-004-2010-8  0.493
2004 London ED, Simon SL, Berman SM, Mandelkern MA, Lichtman AM, Bramen J, Shinn AK, Miotto K, Learn J, Dong Y, Matochik JA, Kurian V, Newton T, Woods R, Rawson R, et al. Mood disturbances and regional cerebral metabolic abnormalities in recently abstinent methamphetamine abusers. Archives of General Psychiatry. 61: 73-84. PMID 14706946 DOI: 10.1001/Archpsyc.61.1.73  0.348
2004 Newton TF, Kalechstein AD, Hardy DJ, Cook IA, Nestor L, Ling W, Leuchter AF. Association between quantitative EEG and neurocognition in methamphetamine-dependent volunteers. Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology. 115: 194-8. PMID 14706488 DOI: 10.1016/S1388-2457(03)00314-6  0.312
2004 Houtsmuller EJ, Notes LD, Newton T, van Sluis N, Chiang N, Elkashef A, Bigelow GE. Transdermal selegiline and intravenous cocaine: safety and interactions. Psychopharmacology. 172: 31-40. PMID 14605792 DOI: 10.1007/S00213-003-1616-6  0.5
2003 Newton TF, Kalechstein AD, Tervo KE, Ling W. Irritability following abstinence from cocaine predicts euphoric effects of cocaine administration. Addictive Behaviors. 28: 817-21. PMID 12726795 DOI: 10.1016/S0306-4603(01)00273-8  0.52
2003 Kalechstein AD, Newton TF, Green M. Methamphetamine dependence is associated with neurocognitive impairment in the initial phases of abstinence. The Journal of Neuropsychiatry and Clinical Neurosciences. 15: 215-20. PMID 12724464 DOI: 10.1176/Jnp.15.2.215  0.346
2003 Newton TF, Cook IA, Kalechstein AD, Duran S, Monroy F, Ling W, Leuchter AF. Quantitative EEG abnormalities in recently abstinent methamphetamine dependent individuals. Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology. 114: 410-5. PMID 12705421 DOI: 10.1016/S1388-2457(02)00409-1  0.38
2002 Kalechstein AD, Newton TF, Leavengood AH. Apathy syndrome in cocaine dependence. Psychiatry Research. 109: 97-100. PMID 11850056 DOI: 10.1016/S0165-1781(01)00354-7  0.503
2001 Hinkin CH, Castellon SA, Hardy DJ, Farinpour R, Newton T, Singer E. Methylphenidate improves HIV-1-associated cognitive slowing. The Journal of Neuropsychiatry and Clinical Neurosciences. 13: 248-54. PMID 11449032 DOI: 10.1176/Jnp.13.2.248  0.315
2001 Newton TF, Ling W, Kalechstein AD, Uslaner J, Tervo K. Risperidone pre-treatment reduces the euphoric effects of experimentally administered cocaine. Psychiatry Research. 102: 227-33. PMID 11440773 DOI: 10.1016/S0165-1781(01)00255-4  0.548
2000 Kalechstein AD, Newton TF, Longshore D, Anglin MD, van Gorp WG, Gawin FH. Psychiatric comorbidity of methamphetamine dependence in a forensic sample. The Journal of Neuropsychiatry and Clinical Neurosciences. 12: 480-4. PMID 11083165 DOI: 10.1176/Jnp.12.4.480  0.306
1999 Newton TF, Kalechstein A, Beckson M, Bartzokis G, Bridge TP, Ling W. Effects of selegiline pretreatment on response to experimental cocaine administration Psychiatry Research. 87: 101-6. PMID 10579543 DOI: 10.1016/S0165-1781(99)00058-X  0.544
1999 Uslaner J, Kalechstein A, Richter T, Ling W, Newton T. Association of depressive symptoms during abstinence with the subjective high produced by cocaine American Journal of Psychiatry. 156: 1444-1446. PMID 10484960 DOI: 10.1176/Ajp.156.9.1444  0.43
1999 Bartzokis G, Beckson M, Newton T, Mandelkern M, Mintz J, Foster JA, Ling W, Bridge TP. Selegiline effects on cocaine-induced changes in medial temporal lobe metabolism and subjective ratings of euphoria. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 20: 582-90. PMID 10327427 DOI: 10.1016/S0893-133X(98)00092-X  0.522
1998 Gan X, Zhang L, Newton T, Chang SL, Ling W, Kermani V, Berger O, Graves MC, Fiala M. Cocaine infusion increases interferon-gamma and decreases interleukin-10 in cocaine-dependent subjects. Clinical Immunology and Immunopathology. 89: 181-90. PMID 9787120 DOI: 10.1006/Clin.1998.4607  0.467
1998 Fiala M, Gan XH, Zhang L, House SD, Newton T, Graves MC, Shapshak P, Stins M, Kim KS, Witte M, Chang SL. Cocaine enhances monocyte migration across the blood-brain barrier. Cocaine's connection to AIDS dementia and vasculitis? Advances in Experimental Medicine and Biology. 437: 199-205. PMID 9666272 DOI: 10.1007/978-1-4615-5347-2_22  0.47
1997 Newton TF, Khalsa-Denison ME, Gawin FH. The face of craving? Facial muscle EMG and reported craving in abstinent and non-abstinent cocaine users. Psychiatry Research. 73: 115-8. PMID 9463845 DOI: 10.1016/S0165-1781(97)00115-7  0.472
1996 Fiala AM, Gan XH, Newton T, Chiappelli F, Shapshak P, Kermani V, Kung MA, Diagne A, Martinez O, Way D, Weinand M, Witte M, Graves M. Divergent effects of cocaine on cytokine production by lymphocytes and monocyte/macrophages: HIV-1 enhancement by cocaine within the blood-brain barrier. Advances in Experimental Medicine and Biology. 402: 145-56. PMID 8787655  0.334
1993 Leuchter AF, Cook IA, Newton TF, Dunkin J, Walter DO, Rosenberg-Thompson S, Lachenbruch PA, Weiner H. Regional differences in brain electrical activity in dementia: use of spectral power and spectral ratio measures. Electroencephalography and Clinical Neurophysiology. 87: 385-93. PMID 7508371 DOI: 10.1016/0013-4694(93)90152-L  0.304
Show low-probability matches.